| Symbol | OGI |
|---|---|
| Name | ORGANIGRAM GLOBAL INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 35 ENGLISH DRIVE, MONCTON, New Brunswick, E1E 3X3, Canada |
| Telephone | +1 506 801-8986 |
| Fax | — |
| — | |
| Website | https://www.organigram.ca |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001620737 |
| Description | Organigram Inc. is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships. Additional info from NASDAQ: |
Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026
Read moreNew Form SCHEDULE 13D/A - ORGANIGRAM GLOBAL INC. <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001193125-26-160395 <b>Size:</b> 427 KB
Read moreOrganigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities
Read moreOrganigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting
Read moreOrganigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH
Read moreOrganigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity
Read more